Nanopharm Ltd (an Aptar Pharma company) provides specialist respiratory drug product development services to clients globally. With world leading expertise and state of the art facilities, high class support is provided from early stage material characterisation, all the way through to clinical manufacture for NCE and generic drug products. Advanced analytical and in-silico tools are also available for alternative pathways to clinical endpoint studies for generic product bioequivalence studies.
The company is regarded as a world leading provider of these services and has been directly involved in the successful development of many products. Owing to the experience and focus of the team, one of the key benefits in working with Nanopharm is the hands-on approach that is provided to client projects, ensuring highly successful outcomes.